Scientific Publications

October 28, 2020 / J Genet Genomics

Phosphatidylinositol 4 kinase-β mutations cause non-syndromic sensorineural deafness and inner ear malformation

X. Su
Y. Feng
S.A. Rahman
S. Wu
G. Li
F. Rüschendorf
L. Zhao
H. Cui
J. Liang
L. Fang
H. Hu
S. Froehler
Y. Yu
G. Patone
O. Hummel
Q. Chen
K. Raile
F.C. Luft
S. Bähring
K. Hussain
W. Chen
J. Zhang
M. Gong

Phosphoinositide conversion inactivates R-RAS and drives metastases in breast cancer

H. Li
L. Prever
M.Y. Hsu
W.T. Lo
J.P. Margaria
M.C. De Santis
C. Zanini
M. Forni
F. Novelli
S. Pece
P.P. Di Fiore
P.E. Porporato
M. Martini
H. Belabed
M. Nazare
V. Haucke
F. Gulluni
E. Hirsch

Impaired cardiovascular reflexes precede desoxycorticosterone acetate-salt hypertension

R. Veelken
K.F. Hilgers
T. Ditting
M. Leonard
J.F. Mann
H. Geiger
F.C. Luft

Wegener`s granulomatosis masquerading as breast cancer

U. Goebel
R. Kettritz
U. Kettritz
U. Thieme
W. Schneider
F.C. Luft

Lymphotoxin, tumour necrosis factor and interleukin-6 gene transcripts are present in Hodgkin and Reed-Sternberg cells of most Hodgkin's disease cases

H.D. Foss
H. Herbst
E. Oelmann
J. Samol
M. Grebe
T. Blankenstein
J. Matthes
Z. Qin
B. Falini
S. Pileri
T. Diamantstein
H. Stein

Interleukin 10 transfected into Chinese hamster ovary cells prevents tumor growth and macrophage infiltration

G. Richter
S. Krueger-Krasagakes
G. Hein
C. Huels
E. Schmitt
T. Diamantstein
T. Blankenstein

Expression of tumor necrosis factor by different tumor cell lines results either in tumor suppression or augmented metastasis

Z. Qin
S. Krueger-Krasagakes
U. Kunzendorf
H. Hock
T. Diamantstein
T. Blankenstein

Mechanisms of rejection induced by tumor cell-targeted gene transfer of interleukin 2, interleukin 4, interleukin 7, tumor necrosis factor, or interferon-gamma

H. Hock
M. Dorsch
U. Kunzendorf
Z. Qin
T. Diamantstein
T. Blankenstein

Eosinophils infiltrating interleukin-5 gene-transfected tumors do not suppress tumor growth

S. Krueger-Krasagakes
W. Li
G. Richter
T. Diamantstein
T. Blankenstein

Vaccinations with tumor cells genetically engineered to produce different cytokines: effectivity not superior to a classical adjuvant

H. Hock
M. Dorsch
U. Kunzendorf
K. Ueberla
Z. Qin
T. Diamantstein
T. Blankenstein